Can scarring in the heart predict trouble for fallot patients?

NCT ID NCT04737135

First seen May 01, 2026 · Last updated Jun 22, 2026 · Updated 10 times

Summary

This study looks at 224 adults who had surgery as children for a heart defect called tetralogy of Fallot. Researchers want to see if scarring (fibrosis) in the heart muscle, measured by MRI and blood tests, is linked to future heart problems like arrhythmias or heart failure. No new treatments are given; the goal is to learn which patients might need extra care.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CONGENITAL HEART DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Hospital Clínic i Provincial de Barcelona

    Barcelona, 08036, Spain

  • Hospital General Universitario Gregorio Marañón

    Madrid, 28007, Spain

  • Hospital Universitari Valle de Hebron

    Barcelona, 08035, Spain

  • Hospital Universitario 12 de Octubre

    Madrid, Madrid, 28041, Spain

  • Hospital Universitario La Paz

    Madrid, 28046, Spain

  • Hospital Universitario Virgen del Rocío

    Seville, 41013, Spain

  • Hospital Universitario y Politécnico La Fe

    Valencia, 46026, Spain

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this study could help doctors identify which patients with repaired tetralogy of Fallot are at higher risk for heart complications, enabling closer monitoring or earlier intervention.

What could go wrong

This is an observational study, not a treatment trial. It may not find a clear link between fibrosis markers and outcomes, or the markers may not be practical for routine use.

Conditions

The condition(s) this trial relates to.

congenital heart disease double outlet right ventricle with subaortic or doubly committed ventricular septal defect with pulmonary stenosis tetralogy of fallot

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.